Biosimilars: A Excessive‑worth Alternative
Options to biologic drugs, often called biosimilars, provide the identical security and effectiveness as the unique medication, and just like generic medication, they drive market competitors.
Why this issues to your plan:
- Biosimilars introduce market competitors, driving down costs.
- They provide extra value‑efficient remedy choices for situations like most cancers, rheumatoid arthritis, and Crohn’s illness.
- IBX employs most well-liked drug methods and unique contracting with biosimilar producers to maximise value financial savings.
- We’re actively monitoring and figuring out alternatives to leverage biosimilars to maximise our value financial savings alternatives for our purchasers.
Web site of Care: Accountable Steering
One among our strongest instruments in combatting rising specialty drug prices on the medical profit is managing the location of care via our MCES program. For a lot of specialty medication administered by a well being care skilled, administration in a physician’s workplace, infusion clinic, or within the dwelling by way of a nurse shouldn’t be solely extra handy to the member, but additionally considerably reduces prices.
The MCES program has saved over $250 million since 2012. Our Utilization Administration procedures and supplier contracting facilitate website of care coordination and considerably scale back the added prices related to the administration of excessive‑value medical specialty medication.
What This Means for You
As an employer, you need to provide advantages that meet the evolving wants of your staff with out compromising plan sustainability. IBX helps you with:
